147 related articles for article (PubMed ID: 32598267)
41. Design, synthesis and biological evaluation of novel 3-substituted 4-anilino-coumarin derivatives as antitumor agents.
Luo G; Muyaba M; Lyu W; Tang Z; Zhao R; Xu Q; You Q; Xiang H
Bioorg Med Chem Lett; 2017 Feb; 27(4):867-874. PubMed ID: 28110871
[TBL] [Abstract][Full Text] [Related]
42. Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies.
Thakur A; Singla R; Jaitak V
Eur J Med Chem; 2015 Aug; 101():476-95. PubMed ID: 26188907
[TBL] [Abstract][Full Text] [Related]
43. Coumarin Derivatives as Anti-inflammatory and Anticancer Agents.
Thomas V; Giles D; Basavarajaswamy GPM; Das AK; Patel A
Anticancer Agents Med Chem; 2017; 17(3):415-423. PubMed ID: 27592545
[TBL] [Abstract][Full Text] [Related]
44. Synthesis, Biological Evaluation and Molecular Docking Study of Cyclic Diarylheptanoids as Potential Anticancer Therapeutics.
Lu Y; Yin W; Alam MS; Kadi AA; Jahng Y; Kwon Y; Rahman AFMM
Anticancer Agents Med Chem; 2020; 20(4):464-475. PubMed ID: 31763968
[TBL] [Abstract][Full Text] [Related]
45. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD
Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065
[TBL] [Abstract][Full Text] [Related]
46. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids.
Kraljević TG; Harej A; Sedić M; Pavelić SK; Stepanić V; Drenjančević D; Talapko J; Raić-Malić S
Eur J Med Chem; 2016 Nov; 124():794-808. PubMed ID: 27639370
[TBL] [Abstract][Full Text] [Related]
47. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors.
Wang G; Wang J; He D; Li X; Li J; Peng Z
Chem Biol Drug Des; 2017 Mar; 89(3):456-463. PubMed ID: 27616456
[TBL] [Abstract][Full Text] [Related]
48. New N-phenylacetamide-linked 1,2,3-triazole-tethered coumarin conjugates: Synthesis, bioevaluation, and molecular docking study.
Akolkar SV; Nagargoje AA; Shaikh MH; Warshagha MZA; Sangshetti JN; Damale MG; Shingate BB
Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000164. PubMed ID: 32776355
[TBL] [Abstract][Full Text] [Related]
49. Design, synthesis, in vitro evaluation, molecular docking and ADME properties studies of hybrid bis-coumarin with thiadiazole as a new inhibitor of Urease.
Alomari M; Taha M; Imran S; Jamil W; Selvaraj M; Uddin N; Rahim F
Bioorg Chem; 2019 Nov; 92():103235. PubMed ID: 31494327
[TBL] [Abstract][Full Text] [Related]
50. Microwave and Conventional Study of Coumarin-Oxadiazole Adducts and their Anti-Microbial Evaluation.
Kapadiya K; Dholaria P
Folia Med (Plovdiv); 2021 Feb; 63(1):105-112. PubMed ID: 33650403
[TBL] [Abstract][Full Text] [Related]
51. Coumarin: a promising scaffold for anticancer agents.
Kaur M; Kohli S; Sandhu S; Bansal Y; Bansal G
Anticancer Agents Med Chem; 2015; 15(8):1032-48. PubMed ID: 25553437
[TBL] [Abstract][Full Text] [Related]
52. DNA-binding activity and cytotoxic and cell-cycle arrest properties of some new coumarin derivatives: a multispectral and computational investigation.
Khosravifar F; Dehghan G; Bidoki SK; Mahdavi M
Luminescence; 2020 Feb; 35(1):98-106. PubMed ID: 31475787
[TBL] [Abstract][Full Text] [Related]
53. Design of Novel Coumarin Derivatives as NUDT5 Antagonists That Act by Restricting ATP Synthesis in Breast Cancer Cells.
Niranjan V; Jayaprasad S; Uttarkar A; Kusanur R; Kumar J
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615284
[TBL] [Abstract][Full Text] [Related]
54. Some new indole-coumarin hybrids; Synthesis, anticancer and Bcl-2 docking studies.
Kamath PR; Sunil D; Ajees AA; Pai KS; Das S
Bioorg Chem; 2015 Dec; 63():101-9. PubMed ID: 26469742
[TBL] [Abstract][Full Text] [Related]
55. One pot synthesis, in silico study and evaluation of some novel flavonoids as potent topoisomerase II inhibitors.
Sarkate AP; Dofe VS; Tiwari SV; Lokwani DK; Karnik KS; Kamble DD; Ansari MHSH; Dodamani S; Jalalpure SS; Sangshetti JN; Azad R; Burra PVLS; Bhandari SV
Bioorg Med Chem Lett; 2021 May; 40():127916. PubMed ID: 33689875
[TBL] [Abstract][Full Text] [Related]
56. Chloro and bromo-pyrazole curcumin Knoevenagel condensates augmented anticancer activity against human cervical cancer cells: design, synthesis,
Chaudhary M; Kumar N; Baldi A; Chandra R; Arockia Babu M; Madan J
J Biomol Struct Dyn; 2020 Jan; 38(1):200-218. PubMed ID: 30784365
[TBL] [Abstract][Full Text] [Related]
57. Synthesis, in vitro antiproliferative activity, and in silico studies of fused tricyclic coumarin sulfonate derivatives.
El-Gamal MI; Oh CH
Eur J Med Chem; 2014 Sep; 84():68-76. PubMed ID: 25016229
[TBL] [Abstract][Full Text] [Related]
58. Coumarin derivatives with anticancer activities: An update.
Song XF; Fan J; Liu L; Liu XF; Gao F
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000025. PubMed ID: 32383190
[TBL] [Abstract][Full Text] [Related]
59. 1,1'-Carbonyldiimidazole (CDI) Mediated Facile Synthesis, Structural Characterization, Antimicrobial Activity, and in-silico Studies of Coumarin- 3-carboxamide Derivatives.
Salar U; Khan KM; Fakhri MI; Hussain S; Tauseef S; Ameer S; Wadood A; Khan H; Perveen S
Med Chem; 2018; 14(1):86-101. PubMed ID: 28641525
[TBL] [Abstract][Full Text] [Related]
60. Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivatives.
Taha M; Shah SAA; Afifi M; Imran S; Sultan S; Rahim F; Khan KM
Bioorg Chem; 2018 Apr; 77():586-592. PubMed ID: 29477126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]